News

Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and Zoloft, has now increased its dividend payout for 16 consecutive years

After tanking in early August, the world’s most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company (NYSE: LLY), the maker of the wildly popular

With many stocks looking overvalued, many investors may be tempted to sell. However, there are several factors to consider before taking profits:

• Time horizon – when an investor will need the

Marvell Technology (NASDAQ: MRVL) insiders are purchasing shares, and there are compelling reasons for investors to take notice. The company is well-positioned to benefit from the growth and

When investors hear that a company will lower prices on its products, their instinctive reaction is to expect a sequential decline in margins and profits, which is not entirely incorrect. However

On Sept. 30, the market delivered a powerful and unambiguous verdict on Draganfly Inc. (NASDAQ: DPRO). Shares of the drone technology company surged over 17%, driven by an unprecedented wave of

SoundHound’s (NASDAQ: SOUN) share price advanced by more than 10% on September 23rd to set a fresh long-term high and potentially break the market out of its trading range. The implication of

In the United States' healthcare sector, a new growth theme is emerging that nearly all companies want to capitalize on. Like artificial intelligence for technology stocks, weight loss drug